(Q35225208)

7 August 2017

1 reference

title

Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: foscarnet (English)

1 reference

7 August 2017

Maintenance therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: Foscarnet (English)

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

cytomegalovirus retinitis

1 December 2023

main subject

1 reference

M. A. Jacobson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1310573

11 September 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

7 August 2017

14 February 1992

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1310573

full work available at URL

11 September 2022

https://api.elsevier.com/content/article/PII:0002934392903348?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

https://api.elsevier.com/content/article/PII:0002934392903348?httpAccept=text/plain

1 December 2023

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

American Journal of Medicine

1 December 2023

published in

1 reference

7 August 2017

volume

92

1 reference

7 August 2017

issue

2A

1 reference

7 August 2017

page(s)

26S-29S

1 reference

Ocular manifestations of acquired immune deficiency syndrome

7 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies

1 December 2023

3

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Prolonged pancytopenia due to combined ganciclovir and zidovudine therapy

1 December 2023

4

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients

1 December 2023

8

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Prevalence of Resistance in Patients Receiving Ganciclovir for Serious Cytomegalovirus Infection

1 December 2023

9

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Antiviral effects of phosphonoformate (PFA, foscarnet sodium)

1 December 2023

10

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Inhibition of human T-cell lymphotropic virus type III in vitro by phosphonoformate

1 December 2023

11

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (Foscarnet)

1 December 2023

12

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Randomized prospective trial of ganciclovir maintenance therapy for cytomegalovirus retinitis

1 December 2023

13

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis

1 December 2023

14

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome

1 December 2023

16

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

A Randomized, Controlled Trial of Foscarnet in the Treatment of Cytomegalovirus Retinitis in Patients with AIDS

1 December 2023

17

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Foscarnet therapy for ganciclovir-resistant cytomegalovirus retinitis in patients with AIDS.

1 December 2023

23

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Foscarnet-Induced Hypocalcemia and Effects of Foscarnet on Calcium Metabolism*

1 December 2023

25

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis

1 December 2023

26

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Foscarnet nephrotoxicity: mechanism, incidence and prevention

1 December 2023

27

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro

1 December 2023

28

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

Increased efficacy of ganciclovir in combination with foscarnet against cytomegalovirus and herpes simplex virus type 2 in vitro and in vivo

1 December 2023

29

1 reference

https://api.crossref.org/works/10.1016/0002-9343(92)90334-8

1 December 2023

Identifiers

1 reference

7 August 2017

1 reference